Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OBE
1901
Obsidian Energy
OBE
$712M
| $2.69M | ﹤0.01% |
404,872
+58,300
| +17% | +$453K |
|
1902
Grupo Aval
AVAL
$6.29B
| $2.68M | ﹤0.01% |
1,060,172
+84,400
| +9% | +$195K |
|
1903
Airgain
AIRG
$72.2M
| $2.67M | ﹤0.01% |
410,836
-16,000
| -4% | -$115K |
|
|
CVSA
1904
Covista Inc
CVSA
$4.49B
| $2.67M | ﹤0.01% |
+75,100
| New | +$2.93M |
|
1905
Enact Holdings
ACT
$6.87B
| $2.66M | ﹤0.01% |
110,200
-1,900
| -2% | -$46.4K |
|
1906
Sasol
SSL
$7.39B
| $2.66M | ﹤0.01% |
169,100
-8,200
| -5% | -$136K |
|
1907
Vishay Intertechnology
VSH
$5.38B
| $2.65M | ﹤0.01% |
123,025
-111,924
| -48% | -$2.36M |
|
1908
ARS Pharmaceuticals
SPRY
$561M
| $2.65M | ﹤0.01% |
311,000
-3,400
| -1% | -$22.1K |
|
1909
RPC Inc
RES
$1.41B
| $2.65M | ﹤0.01% |
297,819
+203,819
| +217% | +$1.84M |
|
|
SCX
1910
DELISTED
The L.S. Starrett Company
SCX
| $2.64M | ﹤0.01% |
358,173
-26,693
| -7% | -$214K |
|
|
NGMS
1911
DELISTED
NeoGames S.A. Ordinary Shares
NGMS
| $2.63M | ﹤0.01% |
216,000
-82,200
| -28% | -$1.24M |
|
|
KWY
1912
Kingsway Corp
KWY
$285M
| $2.62M | ﹤0.01% |
330,315
-27,071
| -8% | -$189K |
|
|
BZUN
1913
Baozun
BZUN
$165M
| $2.62M | ﹤0.01% |
493,616
+335,600
| +212% | +$1.6M |
|
1914
State Street SPDR Portfolio Emerging Markets ETF
SPEM
$17.7B
| $2.61M | ﹤0.01% |
+79,100
| New | +$2.56M |
|
|
BBBY
1915
Bed Bath & Beyond
BBBY
$415M
| $2.6M | ﹤0.01% |
+147,840
| New | +$3.18M |
|
1916
iShares MSCI Canada ETF
EWC
$6.56B
| $2.6M | ﹤0.01% |
79,400
-8,200
| -9% | -$272K |
|
|
SMAR
1917
DELISTED
Smartsheet Inc.
SMAR
| $2.6M | ﹤0.01% |
+66,000
| New | +$2.25M |
|
|
TRTN
1918
DELISTED
Triton International Limited
TRTN
| $2.59M | ﹤0.01% |
+37,606
| New | +$2.38M |
|
1919
Movado Group
MOV
$803M
| $2.58M | ﹤0.01% |
80,100
-34,100
| -30% | -$1.09M |
|
|
BNT
1920
Brookfield Wealth Solutions
BNT
$12B
| $2.58M | ﹤0.01% |
123,750
+68,250
| +123% | +$1.82M |
|
1921
Invesco Preferred ETF
PGX
$3.77B
| $2.58M | ﹤0.01% |
+230,750
| New | +$2.67M |
|
1922
Saga Communications
SGA
$62.1M
| $2.57M | ﹤0.01% |
108,744
-9,534
| -8% | -$235K |
|
1923
Waste Management
WM
$89.8B
| $2.56M | ﹤0.01% |
16,300
-229,100
| -93% | -$36.9M |
|
1924
AmeriServ Financial
ASRV
$85M
| $2.55M | ﹤0.01% |
647,551
-11,133
| -2% | -$43.9K |
|
|
HIMX
1925
Himax Technologies
HIMX
$2.66B
| $2.54M | ﹤0.01% |
408,600
+37,000
| +10% | +$235K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.